Deutsch Japanese

IDKmonitor® Risankizumab drug level ELISA

Article number: Y9671

Test-Category

ELISA

Pack size

96 Tests

Possible sample matrix and volumes

EDTA plasma 10 µl
Serum 10 µl

Incubation periods

  1. 1 hour
  2. 1 hour
  3. 10-20 minutes

Indications

Heart / Kidney

Regulatory Status

CE marked outside EU: RUO (research use only)

IDKmonitor® Risankizumab drug level ELISA is an enzyme immunoassay intended for the quantitative determination of free therapeutic antibody Risankizumab (e. g. Skyrizi) in EDTA plasma and serum. The assay is an in vitro diagnostic medical device and intended to be used by professional users in a laboratory environment. It can be performed manually or using an automated platform. It serves as an aid in therapy monitoring of patients treated with Risankizumab.